What is Cosmo N.V. (CMHC.SW)?

Cosmo N.V. (CMHC.SW) is a stock in the Healthcare sector, Medical - Pharmaceuticals industry. View full analysis on Stocks360.

Cosmo N.V. (CMHC.SW)

Stock analysis · SIX · Healthcare · Medical - Pharmaceuticals

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

1.64

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Cosmo N.V. (CMHC.SW) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Jul 23, 2026

EPS $-0.26 vs est. $-0.03

Missed by $0.23

Proprietary Signals

Signal snapshot temporarily unavailable.

About Cosmo N.V.

Cosmo NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.